Healthcare

Monday morning on the ASX belonged to energy stocks and little else. Fresh United States strikes against Iran over the weekend pushed Brent crude up around 3.3% to roughly US$78.49 a barrel, lifting the Energy sector 0.76% while most of the market drifted lower. …

Immutep Limited attracted outsized attention on the Australian share market on Monday 13 July 2026, with its stock rising about 13.73% to $0.06 in the morning session. The figures are drawn from a market snapshot captured around 11.04am AEST on 20-minute delayed data, and …

OncoSil Medical Limited (ASX:OSL) has announced the successful completion of manufacturing validation activities for its OncoSil™ device, marking an important step toward commercial production of its targeted treatment technology for patients with unresectable locally advanced pancreatic cancer (LAPC).

Cleo Diagnostics Ltd (ASX:COV) has announced another milestone in the development of its ovarian cancer diagnostic technology after completing the commercial assay preparation required to begin formal analytical validation. The update marks the company's transition from development activities into the regulatory data generation stage, …

According to the announcement, INSIGHT-003 has demonstrated a mature median overall survival of 30.9 months in both the overall study population, comprising 51 patients, and in the subgroup of patients with a Tumour Proportion Score of 50% or above, comprising four patients. Immutep states …

The Notice of Allowance relates to US patent application Serial No. 17/611,158, titled 'Crystalline Form of Sofpironium Bromide and Preparation Method Thereof'. The application is directed at intellectual property covering the drug substance for Sofdra, known generically as sofpironium, which Botanix markets as a …

Starpharma Holdings Ltd (ASX: SPL) has attracted significant investor attention in 2026 after its shares almost doubled since the beginning of the year. As of 13 July, the biotechnology company's stock had delivered a year-to-date return of 95.95%, reflecting growing market interest in its …